Get the Weekly Intelligence Brief — top committee picks every Sunday.
COO · NASDAQ · STOCK

Cooper Companies (COO) Stock Analysis

Healthcare Updated August 25, 2026
$75.79
52W $58.89 – $89.83
68/100
$14.87B
64.6
0.82
AI Committee Verdict
Buy
68/100
Conviction: High · 80% agreement · 5 analysts
+1.1%
-0.2%
4.58:1
High

Is COO Bullish or Bearish?

Bullish. Innellis AI committee rates Cooper Companies (The) (COO) Buy with a composite score of 68/100 , based on 5 analysts with 80% agreement. Last updated August 25, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +6.65 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -13.35 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The primary driver is 4 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.

Bull & Bear Case

Bull Case
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
  • News sentiment is positive (+0.40 across 27 articles, 14d) — News
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 25, 2026
Overall Committee Score
68/100
Agreement
80%
Analysts
5
Conviction
High
Sector Rank
Top 4%
of 192 Healthcare peers
Growth Analyst bullish
82 / 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
Technical Analyst neutral
54 / 100 · High confidence
Mixed or range-bound price action
+ Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement
− MACD histogram negative -- bearish momentum
Risk Analyst bullish
70 / 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
70 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.40 across 27 articles, 14d)
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3063.01)
Open Full Terminal →

Investment Thesis Evolution

Committee score strengthened from 59.9 to 68.3.

Analyst-level changes:
  • Growth Analyst: stance neutral->bullish; score 56->82 (+26).
  • Value Analyst abstained (was neutral at 44).

Comparing 2026-08-24 to 2026-08-25 (1 day apart).

Technical Analysis

RSI (14)
59.4
Neutral
MACD Histogram
-0.067
Bearish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Hh Hl
Support
$76.02
Resistance
$77.03
Bollinger %B
0.70
Inside Bands
Price vs Moving Averages
EMA 9
$75.90 Below
EMA 21
$74.68 Above
EMA 50
$72.26 Above
EMA 200
$72.40 Above

Fundamental Analysis

Valuation
65
Growth
79
Profitability
45
Financial Health
70
Cash Flow
70
Valuation
P/E Ratio 64.6×
P/B Ratio 1.80×
PEG Ratio -1.49
Dividend Yield 0.00%
52W High $89.83
52W Low $58.89
Quality & Growth
ROE 455.0%
ROA 302.5%
Gross Margin 6437.1%
Operating Margin 1176.8%
Revenue Growth YoY
Debt / Equity 0.30
AI Fundamental Assessment
P/E ratio of 64.6 (rich relative to a 15-40x range); Price-to-book of 1.8x; PEG ratio of -1.5 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 4.6%; Return on assets of 3.0%; Net margin of 5.6%; Gross margin of 64.4%; Current ratio of 1.27 (tight short-term liquidity); Debt-to-equity of 0.30; Free cash flow per share is positive (2.92); Most recent quarter beat estimates by 9.3%; 4 consecutive earnings beats; EPS growth accelerating (-4.3% -> +10.0% QoQ); Analyst estimates flat over recent quarters
Get the Full COO Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime